Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs GENPREX (GNPX)

Artelo Biosciences, Inc. and GENPREX are both Biotechnology companies. GENPREX is the larger, with a market value of $1.9M against $1.5M — 1.3× the size. Artelo Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 8 and Artelo Biosciences, Inc. on 2.

Valuation

Metric ARTL GNPX Biotechnology median
P/E n/m 0.03 8.50
P/S n/m n/m 9.71
P/B 0.16 0.07 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.31 0.89 0.64
EV/Sales n/m n/m 9.21
Earnings yield (4,348.52%) 3,170.61% (33.15%)
Free cash flow yield (1,553.13%) (1,481.72%) (25.50%)

Profitability

Metric ARTL GNPX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (203.86%) (56.36%)
Return on assets (234.30%) (157.40%) (48.04%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL GNPX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 31.57% 93.48% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL GNPX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 6.76 4.72
Net debt to EBITDA 0.05 0.50 0.96

Dividend

Metric ARTL GNPX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTL GNPX Biotechnology median
Market cap 1.50m 1.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack